amantadine has been researched along with Psychoses, Drug in 21 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " Drugs used to treat PD, such as levodopa, offer symptomatic relief but often have neuropsychiatric adverse effects, most prominently psychosis and delirium." | 4.79 | Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment. ( Camicioli, R; Ganzini, L; Young, BK, 1997) |
| "Amantadine is an antiviral agent that is also used in the treatment of parkinsonism and neuroleptic-induced extrapyramidal symptoms." | 1.28 | Acute psychosis after amantadine overdose. ( Bessen, HA; Snoey, ER, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (66.67) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turbayne, AKB | 1 |
| Xu, TT | 1 |
| Swaminathan, A | 1 |
| Smith, EJ | 1 |
| Zweije-Hofman, IL | 1 |
| van der Zee, HJ | 1 |
| van Nieuwenhuizen, O | 1 |
| Hausner, RS | 1 |
| Stroe, AE | 1 |
| Hall, J | 1 |
| Amin, F | 1 |
| Yang, CC | 1 |
| Deng, JF | 1 |
| Young, BK | 1 |
| Camicioli, R | 1 |
| Ganzini, L | 1 |
| Sunohara, N | 1 |
| Przuntek, H | 1 |
| Cohen, MR | 1 |
| Borison, RL | 1 |
| Snoey, ER | 1 |
| Bessen, HA | 1 |
| Ambrozi, L | 1 |
| Birkmayer, W | 1 |
| Danielczyk, W | 1 |
| Neumayer, E | 1 |
| Riederer, P | 1 |
| Ngai, SH | 1 |
| Wolf, SM | 1 |
| Davis, RL | 1 |
| Armbruster, KF | 1 |
| Rahn, AC | 1 |
| Ing, TS | 1 |
| Halper, IS | 1 |
| Oyama, JH | 1 |
| Klawans, HL | 1 |
| Albert, E | 1 |
| Critchley, E | 1 |
| Völler, G | 1 |
| Diehl, LW | 1 |
| Fahn, S | 1 |
| Craddock, G | 1 |
| Kumin, G | 1 |
6 reviews available for amantadine and Psychoses, Drug
| Article | Year |
|---|---|
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.
Topics: Aging; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Cholinergic | 1997 |
[Toxic and adverse neurological effects of anti-parkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesi | 1999 |
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; | 1979 |
[Biochemical aspects of human behavior].
Topics: Amantadine; Behavior; Biogenic Amines; Brain; Depression; Dihydroxyphenylalanine; Dopamine; Epinephr | 1973 |
Parkinsonism, levodopa, and anesthesia.
Topics: Amantadine; Anesthesia; Animals; Apomorphine; Benperidol; Blood-Brain Barrier; Brain; Cardiovascular | 1972 |
[Therapy and problems of parkinsonism].
Topics: Adult; Aged; Amantadine; Animals; Antidepressive Agents; Apomorphine; Brain Chemistry; Brain Stem; D | 1971 |
1 trial available for amantadine and Psychoses, Drug
| Article | Year |
|---|---|
Anti-parkinson drugs in the Batten-Spielmeyer-Vogt syndrome; a pilot trial.
Topics: Adolescent; Adult; Amantadine; Antiparkinson Agents; Benserazide; Drug Combinations; Humans; Levodop | 1982 |
14 other studies available for amantadine and Psychoses, Drug
| Article | Year |
|---|---|
Amantadine in Chinese 'Cold and Flu' tablets: the cause of psychosis in a healthy man.
Topics: Amantadine; Dopamine Agents; Humans; Male; Multi-Ingredient Cold, Flu, and Allergy Medications; Nonp | 2018 |
Amantadine-induced psychosis in a young healthy patient.
Topics: Adult; Amantadine; Antiviral Agents; Humans; Influenza, Human; Male; Psychoses, Substance-Induced | 2008 |
Amantadine-associated recurrence of psychosis.
Topics: Aged; Amantadine; Female; Humans; Parkinson Disease; Psychoses, Substance-Induced; Recurrence; Schiz | 1980 |
Psychotic episode related to phenylpropanolamine and amantadine in a healthy female.
Topics: Adult; Amantadine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Phenylpropanolamine; P | 1995 |
Anticholinergic syndrome with severe rhabdomyolysis--an unusual feature of amantadine toxicity.
Topics: Adult; Amantadine; Antiviral Agents; Humans; Male; Psychoses, Substance-Induced; Rhabdomyolysis | 1997 |
Amantadine and alpha-methyldopa: effects and interactions.
Topics: Amantadine; Drug Therapy, Combination; Humans; Methyldopa; Psychoses, Substance-Induced | 1979 |
Amantadine-induced psychosis in a geriatric patient with renal disease.
Topics: Aged; Amantadine; Female; Humans; Kidney Failure, Chronic; Parkinson Disease; Psychoses, Substance-I | 1979 |
Acute psychosis after amantadine overdose.
Topics: Adult; Amantadine; Diagnosis, Differential; Diphenhydramine; Drug Synergism; Female; Hallucinations; | 1990 |
Permanent dementia in idiopathic Parkinsonism treated with levodopa.
Topics: Aged; Amantadine; Brain; Dihydroxyphenylalanine; Electroencephalography; Humans; Male; Parkinson Dis | 1973 |
Amantadine toxicity in a patient with renal insufficiency.
Topics: Amantadine; Dose-Response Relationship, Drug; Female; Humans; Influenza, Human; Kidney Failure, Chro | 1974 |
Levodopa and amantadine in the treatment of Parkinsonism.
Topics: Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Movement Disorders; Nau | 1972 |
[Amantadine therapy of Parkinson's syndrome. Comment on L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsnism"].
Topics: Amantadine; Edema; Humans; Hypotension; Parkinson Disease; Psychoses, Substance-Induced; Sulfates | 1972 |
[Nil nocere. Adverse effects of amantadine therapy of parkinsonism. Summary to E.W. Fünfgeld: "Long-time therapy of parkinsonism with amantadine sulfate" and to G. Völler: "Amantadine therapy of parkinsonism"].
Topics: Amantadine; Humans; Intracranial Arteriosclerosis; Nephrotic Syndrome; Parkinson Disease; Psychoses, | 1972 |
Acute toxic psychosis from suicidal overdosage of amantadine.
Topics: Acute Disease; Amantadine; Blood-Brain Barrier; Chlorpromazine; Humans; Male; Middle Aged; Parkinson | 1971 |